New cancer clinical trial: A Study of PET/CT Scan With 68Ga-labeled PSMA Ligand to Evaluate Prostate Cancer After Radical Prostatectomy
Published on: June 27, 2017 at 12:00PM
Conditions: Prostate Adenocarcinoma; Prostate Cancer
Interventions: Drug: Ga-HBED-iPSMA PET; Diagnostic Test: CT; Diagnostic Test: MRI
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting – verified June 2017
http://ift.tt/2sqnl0c
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM